Search

everythinglearnresearchcommunity

for

Search:↓

Using 5α-reductase inhibitors for hair loss may increase the risk of dry eye disease.

Most patients with chronic kidney disease had skin issues like paleness and dry skin, and treating these can improve their lives.

Inositol was more effective than metformin in improving menstrual cycles and pregnancy rates in PCOS patients.

Aging affects hair density and skin health, and Behcet's disease, a complex condition with no specific test, involves sores and systemic issues, treated with various medications.

Gastrointestinal issues are important risk factors for sebaceous gland diseases in Han adolescents.

Zinc is vital for immune health, growth, and preventing diarrhea.

A certain genetic variant in the androgen receptor may predict the severity of COVID-19 in men.

Activating autophagy in dogs with certain diseases improves their skin and hair.

Certain probiotics can help improve skin conditions like atopic dermatitis, but more research is needed.

Alopecia areata greatly affects quality of life, needing psychological support.

Alopecia areata patients have a higher risk of subclinical atherosclerosis, and carotid ultrasound can help assess their cardiovascular risk.

Mesenchymal stromal cells may help treat severe COVID-19, but more research is needed to confirm their effectiveness.

Experts agree on the need for standardized definitions and education for post-COVID-19 conditions.

Higher MIF levels in alopecia areata patients suggest it could be a treatment target and disease predictor.

IMA may indicate oxidative stress in skin and hair disorders, but more research is needed.

Total glucosides of paeony can help treat skin conditions but need more research for clinical use.

More lesions mean more severe alopecia areata.

Lower survivin levels in blood are linked to more severe and progressing alopecia areata.

Kerion cases had longer disease duration but responded well to antifungal treatments.

Hydroxychloroquine may help delay skin damage in lupus patients.

Older age at onset of alopecia areata leads to less severe and shorter episodes, with most patients experiencing significant hair regrowth.

Mostly postmenopausal Caucasian women get Frontal Fibrosing Alopecia, which often includes eyebrow loss and has limited treatment success.

Alopecia areata severity is influenced by factors like long disease duration, relapses, treatment response, and mental health, leading to the creation of a new severity measurement tool.

There is no cure for alopecia areata, and treatment success depends on the individual's situation.

Younger age, longer disease duration, frequent wig use, and lower education levels worsen quality of life in CCCA patients.

Alopecia areata is more common in women, often appears as patchy hair loss, and is usually treated with steroid injections and minoxidil.

Intravenous methylprednisolone helped over half of alopecia areata patients regrow hair, but many relapsed.

Real-life dosing of biologics for plaque psoriasis often deviates from recommended guidelines, especially for high-need patients.

Antioxidants improved hair growth in alopecia areata patients regardless of disease duration.

Diphenylcyclopropenone (DPCP) can help regrow hair in many alopecia areata patients but may cause side effects and relapses.